Santé
22.05.2026Résumé IA
Experimental Drug MW150 Shows Promise in Reducing Brain Inflammation During Alcohol Withdrawal
Scientists from the University of Kentucky have found that the experimental drug MW150 can reduce brain inflammation associated with alcohol withdrawal. Originally developed for dementia and Alzheimer's, MW150 targets the p38α MAPK pathway, which is linked to neuroinflammation.
Л
Лента.ру